The results indicated that CD44 was detected in TNBC cells, such as MDA-MB-231, derived from a metastatic site of human breast cancer compared to the HER2+ breast cancer cells, except for the AU-565 cell line, which was isolated from a metastatic site of human breast cancer [23]. The gene discussed is CD44; the disease is breast carcinoma.